Form 8-K - Current report:
SEC Accession No. 0001193125-26-162667
Filing Date
2026-04-20
Accepted
2026-04-20 06:59:24
Documents
9
Period of Report
2026-04-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20260420.htm   iXBRL 8-K 44037
  Complete submission text file 0001193125-26-162667.txt   148960

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20260420.xsd EX-101.SCH 25023
12 EXTRACTED XBRL INSTANCE DOCUMENT neog-20260420_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 26873326
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)